Media release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Journal/
conference: JAMA Network Open
conference: JAMA Network Open
Research:Paper
Organisation/s:
Omaha Public School District, US; University of Nebraska Medical Center, US
Funder:
Conflict of Interest Disclosures: Ms Carstens reported receiving grants from Omaha Public Schools during the conduct of the study. Dr Lawler reported receiving grants from the Susan Buffett Foundation during the conduct
of the study, stock options for an advisory role from Kinsa Health, and personal fees from Takeda Pharmaceuticals for membership on a scientific advisory committee outside the submitted work. Dr Campbell reported receiving partial funding for the NULirt software platform used in this study through the Nebraska Public Health Laboratory
and the University of Nebraska Medical Center (NULirt is a registered invention with the University of Nebraska Medical Center). Dr Santarpia reported receiving grants from the Sherwood Foundation during the conduct of the study. Dr Bartelt-Hunt reported receiving grants from Omaha Public Schools during the conduct of the study. Dr Wiley reported being CEO of PraesensBio LLC outside the submitted work. Dr Broadhurst reported receiving grants from Omaha Public Schools during the conduct of the study. No other disclosures were reported.
Funding/Support: This project received funding from the Sherwood Foundation.
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.